VCV001807728.1 - ClinVar

GRCh37/hg19 16p13.3(chr16:2021144-2266791)x1

Germline

Classification

The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.

(1)

Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.

Pathogenic

criteria provided, single submitter

Somatic

No data submitted for somatic clinical impact

Somatic

No data submitted for oncogenicity

Variant Details

Identifiers

GRCh37/hg19 16p13.3(chr16:2021144-2266791)x1

Variation ID: 1807728 Accession: VCV001807728.1

Type and length

copy number loss, -

Location

Cytogenetic: 16p13.3 16: 2021144-2266791 (GRCh37) [ NCBI UCSC ]

Timeline in ClinVar

	First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.	Last submission Help The date of the most recent submission for each type of classification for this variant.	Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline	Dec 31, 2022	Dec 31, 2022	Jul 30, 2021

HGVS

Protein change

Other names

Canonical SPDI

Functional consequence Help The effect of the variant on RNA or protein function, based on experimental evidence from submitters.

Global minor allele frequency (GMAF) Help The global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.

Allele frequency Help The frequency of the allele represented by this VCV record.

Links

VarSome

Genes

Gene	OMIM	ClinGen Gene Dosage Sensitivity Curation		Variation Viewer Help Links to Variation Viewer, a genome browser to view variation data from NCBI databases.	Related variants
Gene	OMIM	HI score Help The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.	TS score Help The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.		Within gene Help The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants.	All Help The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene.
PKD1		Sufficient evidence for dosage pathogenicity	No evidence available	GRCh38 GRCh38 GRCh37	3868	4467
TSC2		Sufficient evidence for dosage pathogenicity	No evidence available	GRCh38 GRCh37	10764	10963
BRICD5	-	-	-	GRCh38 GRCh37	25	82
CASKIN1		-	-	GRCh38 GRCh37	134	185
GFER		-	-	GRCh38 GRCh38 GRCh37	91	209
MIR1225		-	-	GRCh38 GRCh37	-	108
MLST8		-	-	GRCh38 GRCh37	14	71
NOXO1		-	-	GRCh38 GRCh38 GRCh37	-	105
NPW		-	-	GRCh38 GRCh38 GRCh37	8	70
NTHL1		-	-	GRCh38 GRCh37	1522	1643

There are 7 more genes affected by this variant. See the full set of genes in Variation Viewer (GRCh37) and ClinGen Dosage Sensitivity Map.

Conditions - Germline

Condition Help The condition for this variant-condition (RCV) record in ClinVar.	Classification Help The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions)	Review status Help The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status.	Last evaluated Help The most recent date that a submitter evaluated this variant for the condition.	Variation/condition record Help The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page.
not provided	Pathogenic (1)	criteria provided, single submitter	Jul 30, 2021	RCV002472534.1

Submissions - Germline

Classification Help The submitted germline classification for each SCV record. (Last evaluated)	Review status Help Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria)	Condition Help The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant.	Submitter Help The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar.	More information Help This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter.
Pathogenic (Jul 30, 2021)	criteria provided, single submitter (ACMG/ClinGen CNV Guidelines, 2019) Method: clinical testing	not provided Affected status: unknown Allele origin: unknown	Quest Diagnostics Nichols Institute San Juan Capistrano Accession: SCV002772402.1 First in ClinVar: Dec 31, 2022 Last updated: Dec 31, 2022	Comment: This imbalance is expected to cause phenotypic and/or developmental abnormalities. This deletion includes multiple genes, notably TSC2 and PKD1. Whole gene and intragenic deletions involving … (more) This imbalance is expected to cause phenotypic and/or developmental abnormalities. This deletion includes multiple genes, notably TSC2 and PKD1. Whole gene and intragenic deletions involving the TSC2 gene cause tuberous sclerosis complex (TSC; OMIM 613254), an autosomal dominant multisystem disorder characterized by hamartomas in multiple organ systems, including the brain, skin, heart, kidneys, and lung. These changes can result in epilepsy, learning difficulties, behavioral problems, and renal failure, among other complications (PMID 17005952). Autosomal dominant polycystic kidney disease-1 with or without polycystic liver disease (PKD1; OMIM 173900) is caused by heterozygous loss of the PKD1 gene. The cardinal manifestations of the disorder are renal cysts, liver cysts, and intracranial aneurysm, although acute and chronic pain and nephrolithiasis are common complications. Approximately half of patients have end-stage renal disease by the age of 60 years with typical age of onset in middle life, yet the age range can be widely variable (PMID 10655152). Larger heterozygous deletions, involving both TSC2 and PKD1, result n the TSC2/PKD1 contiguous gene syndrome (PKDTS; PMIDs 22169896, 18818683, 14695542, 17185137). PKDTS has been identified in patients with tuberous sclerosis complex and early-onset severe autosomal dominant polycystic kidney disease. (less)

Comment:

This imbalance is expected to cause phenotypic and/or developmental abnormalities. This deletion includes multiple genes, notably TSC2 and PKD1. Whole gene and intragenic deletions involving the TSC2 gene cause tuberous sclerosis complex (TSC; OMIM 613254), an autosomal dominant multisystem disorder characterized by hamartomas in multiple organ systems, including the brain, skin, heart, kidneys, and lung. These changes can result in epilepsy, learning difficulties, behavioral problems, and renal failure, among other complications (PMID 17005952). Autosomal dominant polycystic kidney disease-1 with or without polycystic liver disease (PKD1; OMIM 173900) is caused by heterozygous loss of the PKD1 gene. The cardinal manifestations of the disorder are renal cysts, liver cysts, and intracranial aneurysm, although acute and chronic pain and nephrolithiasis are common complications. Approximately half of patients have end-stage renal disease by the age of 60 years with typical age of onset in middle life, yet the age range can be widely variable (PMID 10655152). Larger heterozygous deletions, involving both TSC2 and PKD1, result n the TSC2/PKD1 contiguous gene syndrome (PKDTS; PMIDs 22169896, 18818683, 14695542, 17185137). PKDTS has been identified in patients with tuberous sclerosis complex and early-onset severe autosomal dominant polycystic kidney disease.

Germline Functional Evidence

There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar.

Comment:

Citations for germline classification of this variant

There are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar.

Text-mined citations for this variant ...

Record last updated Dec 31, 2022

ClinVar Genomic variation as it relates to human health

GRCh37/hg19 16p13.3(chr16:2021144-2266791)x1

Variant Details

Genes

Conditions - Germline

Submissions - Germline

Germline Functional Evidence

Citations for germline classification of this variant

Text-mined citations for this variant ...